Newsletter of MEDICA | View in browser | Deutsch | Print
Header of MEDICA Newsletter

Automated cell production for better therapies

Dear Sir or Madam,

Have you ever wondered what the future of cell and gene therapy might look like? The “RauPE” project relies on automated processes to produce therapeutic vesicles efficiently and cost-effectively. Find out in our interview what opportunities this opens up for medicine.

An exciting insight for a successful and healthy new year!

Tim Plato
Editorial team MEDICA-tradefair.com

Table of Contents
Interview: Gene therapy through automated cell production
Newsletter Service

Better gene therapy through automated cell particle production

Interview - LAB & DIAGNOSTICS
Image: Person examining cell cultures in a laboratory
How can automated processes improve the production of cell particles for therapies? Learn how researchers are working on scalable solutions to make gene therapies more cost-effective and accessible.
Click here for the interview
Gene therapy through automated cell production
Discover more from the LAB & DIAGNOSTICS sphere
To top

The use of AI in brain cancer diagnosis, monitoring and treatment

News

DIGITAL HEALTH
New recommendations, published in The Lancet Oncology, provide new guidance for the use of artificial intelligence (AI) in the diagnosis and treatment of brain cancer. The goal is to enable more objective tumor measurements and improve patient care through standardized AI applications.
read more
To top

For the first time: defibrillator with sternum electrode implanted

News

MED TECH & DEVICES
A defibrillator with a sternum electrode was implanted for the first time at University Medical Center Göttingen (UMG). The Aurora System provides a gentler alternative to conventional therapies for sudden cardiac arrest, offering new perspectives particularly for specific patient groups.
read more
To top

Ultrasound as a key tool for brain research

News

MED TECH & DEVICES
Ultrasound, once primarily used for imaging, is emerging as a precise and non-invasive tool for brain research and therapy. Researchers from the University of Plymouth, Stanford University, and Attune Neurosciences highlight its potential in a new PLOS Biology article, detailing its applications and challenges.
read more
To top

Newsletter Service

You like our newsletter? Then please recommend us: Forward this newsletter or the link www.MEDICA.de/news_login_2 to your friends and colleagues.

If you have difficulties with your order, please write an e-mail to medica-redaktion@messe-duesseldorf.de.
To top
Legal disclaimer

Messe Düsseldorf GmbH
Messeplatz, Stockumer Kirchstr. 61
40474 Düsseldorf, Germany

Phone: +49 211 4560-01
Fax: +49 211 4560-668
www.messe-duesseldorf.de
info@messe-duesseldorf.de

County Court Düsseldorf HRB 63

Board of Managing Directors: Wolfram N. Diener (Chairman), Marius Berlemann, Bernhard J. Stempfle

Chairman of Supervisory Board: Mayor Dr. Stephan Keller

Messe Düsseldorf GmbH processes personal data relating to you. You can find more information - also on your rights - in the privacy policy of Messe Düsseldorf GmbH available at www.messe-duesseldorf.de/privacy. In principle, i.e. subject to legal restrictions, you may at any time object to the processing of your personal data either on the aforementioned website, via e-mail to privacy@messe-duesseldorf.de or via postal mail to Messe Düsseldorf GmbH, G2-RV, PF 101006, 40001 Düsseldorf, Germany.

Facebook LinkedIn YouTube

Should you no longer wish to receive our newsletter, please click here.